| 111 |
The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia |
2019 |
| 112 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 113 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 114 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 115 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 116 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 117 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 118 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 119 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
| 120 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
